Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2026-01-04 @ 5:52 PM
Study NCT ID:
NCT00623805
Status:
COMPLETED
Last Update Posted:
2014-08-08
First Post:
2008-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
Sponsor:
Hoffmann-La Roche